E71.518
Other disorders of peroxisome biogenesis
Clinical Classification Guidelines
Medical Intelligence & Overview
Disorders of peroxisome biogenesis are a group of rare genetic conditions that affect how peroxisomes develop and function within cells. Peroxisomes are tiny structures that help break down fatty acids and detoxify harmful substances, playing a crucial role in maintaining cellular health. When these organelles are improperly formed or malfunctioning, it can lead to a range of health issues, some of which may affect the nervous system, liver, and other organs. The ICD-10 code E71.518 covers various other disorders related to the abnormal formation of peroxisomes that do not fall into more specific categories.
Causes & Symptoms
Clinical Causes: Mutations in genes responsible for peroxisome formation and function Inherited genetic factors transmitted from parent to child Rare genetic syndromes affecting cellular organelle biogenesis Potentially, environmental factors that interfere with cell development (though less common)
Key Symptoms: Developmental delays or intellectual disabilities Muscle weakness or failure to meet developmental milestones Eye abnormalities, such as cataracts or retinal issues Liver problems, including hepatomegaly or liver dysfunction Progressive neurological symptoms Failure to thrive or poor growth in infancy Distinct facial features in some cases Skeletal abnormalities
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Specific tests may include measuring the activity levels of peroxisomal enzymes in blood or tissue samples. Genetic testing can identify mutations in genes associated with peroxisome biogenesis disorders. Imaging studies like MRI might be used to assess neurological involvement. Due to the rarity of these conditions, diagnosis often requires consultation with specialists experienced in metabolic and genetic disorders.
Treatment Protocols: Currently, there is no cure for disorders of peroxisome biogenesis. Management focuses on alleviating symptoms and preventing complications. This may include specialized nutritional support, physical and occupational therapy, and medications to manage specific symptoms. Regular monitoring by healthcare providers skilled in metabolic disorders is essential for early detection and treatment of potential complications. Supportive therapies aim to improve quality of life and developmental outcomes where possible.
Clinical Advice & FAQs
Billing Guidance
Is E71.518 a billable ICD-10 code?
Yes, E71.518 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.518?
Clinical documentation must specify the nature of Other disorders of peroxisome biogenesis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference